Chang Shu Selected Research

antithrombin Cambridge II

9/2010

Antithrombin Cambridge II(A384S) mutation frequency and antithrombin activity levels in 120 of deep venous thrombosis and 150 of cerebral infarction patients in a single center in Southern China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chang Shu Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 06/2011
22	Aortic Dissection 01/2022 - 08/2011
18	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 07/2014
12	Endoleak 04/2022 - 08/2011
11	Glioma (Gliomas) 01/2022 - 06/2015
10	Bites and Stings (Sting) 01/2019 - 06/2012
9	Infections 01/2022 - 06/2009
7	Pre-Eclampsia (Preeclampsia) 10/2022 - 01/2014
6	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2016
5	Aneurysm (Aneurysms) 01/2021 - 10/2011
5	Carcinoma (Carcinomatosis) 10/2019 - 10/2003
4	Thoracic Aorta Dissection 04/2022 - 01/2017
4	Inflammation (Inflammations) 02/2022 - 01/2021
4	Thoracic Aortic Aneurysm 02/2022 - 01/2017
4	Hyperplasia 01/2022 - 03/2018
4	Virus Diseases (Viral Diseases) 01/2022 - 08/2014
4	Ulcer 10/2021 - 01/2017
4	Thrombosis (Thrombus) 04/2021 - 04/2012
4	Stomach Neoplasms (Stomach Cancer) 02/2021 - 01/2014
3	Renal Insufficiency (Renal Failure) 02/2022 - 08/2011
3	Carcinogenesis 01/2022 - 12/2016
3	Aortic Aneurysm (Aneurysm, Aortic) 01/2022 - 10/2020
3	Lung Injury 12/2021 - 01/2020
3	Marfan Syndrome (Marfan's Syndrome) 10/2021 - 12/2012
3	Stroke (Strokes) 07/2021 - 08/2011
3	Hypertension (High Blood Pressure) 01/2021 - 04/2016
3	Asthma (Bronchial Asthma) 01/2021 - 09/2006
3	Rupture 10/2020 - 11/2018
3	Atherosclerosis 10/2020 - 01/2016
3	Neutropenia 01/2020 - 01/2014
3	Diarrhea 01/2020 - 11/2016
3	Wounds and Injuries (Trauma) 01/2020 - 12/2011
3	Hemorrhage 10/2019 - 05/2011
3	Diverticulum 09/2019 - 01/2015
3	Neoplasm Metastasis (Metastasis) 01/2019 - 07/2015
3	False Aneurysm (Pseudoaneurysm) 11/2018 - 06/2009
3	Neointima 01/2018 - 07/2011
2	Portal Hypertension 01/2022 - 01/2021
2	Peripheral Arterial Disease 01/2022 - 01/2021
2	Pathologic Constriction (Stenosis) 01/2022 - 10/2020
2	Arteriovenous Fistula 06/2021 - 02/2012
2	Pulmonary Embolism 01/2021 - 01/2021
2	Thrombophilia 01/2021 - 09/2010
2	Aortic Coarctation 10/2020 - 02/2014

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2013
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2014
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2014
11	navitoclaxIBA 08/2020 - 07/2014
8	MicroRNAs (MicroRNA)IBA 01/2021 - 06/2015
6	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2019 - 12/2013
5	CytokinesIBA 01/2021 - 09/2006
4	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2016
4	InterferonsIBA 12/2021 - 06/2012
4	Messenger RNA (mRNA)IBA 05/2021 - 10/2003
4	Transcription Factors (Transcription Factor)IBA 06/2019 - 12/2014
4	Interferon Type IIBA 01/2019 - 06/2012
4	Drug CombinationsIBA 11/2018 - 11/2015
3	Circular RNAIBA 10/2022 - 08/2019
3	RNA (Ribonucleic Acid)IBA 02/2022 - 01/2020
3	1,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA 02/2022 - 12/2021
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 07/2011
3	Blood Substitutes (Artificial Blood)IBA 01/2022 - 06/2009
3	EnzymesIBA 01/2022 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2015
3	Phosphotransferases (Kinase)IBA 10/2021 - 12/2016
3	LipidsIBA 10/2021 - 03/2007
3	AntigensIBA 08/2020 - 09/2006
3	CreatinineIBA 01/2020 - 09/2005
3	CholesterolIBA 10/2019 - 02/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2013
3	Peptides (Polypeptides)IBA 03/2018 - 09/2016
3	OTX015IBA 01/2018 - 05/2017
3	Deubiquitinating EnzymesIBA 09/2016 - 11/2015
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2015 - 03/2008
2	Hematoxylin (Haematoxylon)IBA 01/2022 - 07/2011
2	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 01/2022
2	Competitive Endogenous RNAIBA 01/2022 - 08/2019
2	SolutionsIBA 01/2022 - 01/2022
2	LipopolysaccharidesIBA 01/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 01/2018
2	Neutralizing AntibodiesIBA 12/2021 - 12/2016
2	C 684IBA 10/2021 - 01/2020
2	UbiquitinIBA 10/2021 - 01/2018
2	TropoelastinIBA 05/2021 - 03/2018
2	ElastinIBA 05/2021 - 03/2018
2	Opioid Analgesics (Opioids)IBA 01/2021 - 06/2015
2	BilirubinIBA 01/2021 - 02/2019
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2020 - 01/2018
2	PanobinostatIBA 10/2020 - 01/2018

Therapy/Procedure

24	Therapeutics 02/2022 - 01/2015
23	Stents 04/2022 - 08/2011
21	Endovascular Aneurysm Repair 04/2022 - 08/2011
6	Drug Therapy (Chemotherapy) 01/2022 - 06/2013
4	Radiotherapy 01/2022 - 07/2011
3	Ligation 06/2021 - 06/2009
3	Surgical Amputation (Amputations) 04/2021 - 06/2009
3	Hepatectomy 01/2021 - 11/2018
3	Immunotherapy 08/2016 - 09/2006
2	Prostheses and Implants (Prosthesis) 01/2022 - 11/2017
2	Conservative Treatment 04/2021 - 12/2012